China SXT Pharmaceuticals (SXTC.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug1

China SXT Pharmaceuticals released FY2025 Q3 earnings on July 31 (EST) with actual revenue of USD 0 and EPS of USD 0

03:00

China SXT Pharmaceuticals released FY2025 9 Months Earnings on July 31 (EST), actual revenue USD 1.285 M, actual EPS USD -2.4989

03:00

China SXT Pharmaceuticals released FY2025 earnings on July 31 (EST), actual revenue USD 1.741 M, actual EPS USD -2.3211

03:00

China SXT Pharmaceuticals released FY2025 Q4 earnings on July 31 (EST), actual revenue USD 455.71 K, actual EPS USD -0.5119

03:00

Jul15

China Susunton Pharmaceutical to Hold Extraordinary General Meeting on Dual Class Structure Proposal

17:50

Jun16

China Sushton Pharmaceuticals issues 90 million shares

16:03

Schedules & Filings

Schedules

Filings

Jul31

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 455.71 K, Net Income -1.251 M, EPS -0.5119

Mar28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 414.75 K, Net Income -401.28 K, EPS -0.9934

Feb25

Reverse Stock Split(EST)

1-for-8 Reverse Stock Split

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More